BIO-KEY INTERNATIONAL INC (BKYI)
NASDAQIndustrialsInformation Technology ServicesSnapshot 2026-11-05
$2.37+0.42%
Close 2026-11-05 · 1-day change
NASDAQIndustrialsInformation Technology ServicesSnapshot 2026-11-05
QuarterlyIQ Insights · BKYI
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -71.5% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| 65.8% |
Growth built into the price is above our model estimate.
The price assumes 137.2 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of —
BKYI — capital allocation — Unregistered Sale of Equity Securities
Dated 2026-10-02
Unregistered Sale of Equity Securities. The information in
Why it matters: BIO-key set a second-half goal for revenue growth and profit. Its August release said Q2 revenue was $1.92M and net loss was $577K.
Supportive ifOn November 13, the Q3 report shows revenue above Q3 2025 and net income above zero.
Worry ifThe Q3 report shows revenue at or below Q3 2025, or a net loss.
Why it matters: BIO-key regained Nasdaq compliance, but Nasdaq set a one-year monitor through July 6, 2027. A new breach could threaten its listing again.
Worry ifA Nasdaq notice by July 6, 2027, says BIO-key failed to meet a listing rule during the monitor.
Less concerning ifThe monitor ends on July 6, 2027, and Nasdaq confirms the company remains in compliance.
Why it matters: Management linked its second-half outlook to government and bank projects. New signed work would show that recent partnerships are turning into sales.
Supportive ifBIO-key names a new signed contract tied to its work in Saudi, Portugal, or Jordan. It also discloses a customer or contract value.
Worry ifBy the next quarterly report, BIO-key reports no new signed contract from those efforts. It also reports no related revenue.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$370 on $10,000 · ±3.7% | How much price usually moves either way. |
| Bad day | $1,101 loss on $10,000 · 11.0% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $8,398 loss on $10,000 · 84.0% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.